GH Secretagogues

Ipamorelin

Catalog #: IP

Ipamorelin is the most GH-selective ghrelin receptor agonist identified. A pentapeptide that stimulates GH release without elevating ACTH, cortisol, or prolactin — the gold standard for clean GH axis research.

Catalog Number IP
Sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Target GHS-R1a (ghrelin receptor)
Molecular Weight ~711.9 Da

Available SKUs

Model Specification MOQ
IP10 10mg / 10ml 1 vial
Ships within 5-7 business days
Certificate of Analysis included
Quality guaranteed

Product Overview

Ipamorelin is the most GH-selective ghrelin receptor agonist identified. A pentapeptide that stimulates GH release without elevating ACTH, cortisol, or prolactin — the gold standard for clean GH axis research.

Research Applications

  • Most GH-selective secretagogue peptide ever identified
  • No significant ACTH, cortisol, or prolactin stimulation
  • Potent ghrelin receptor (GHS-R1a) agonist via calcium signaling
  • Synergistic with GHRH analogs (CJC-1295) in GH release
  • Dose-response ceiling effect — physiological GH amplitudes

Key Features

  • Developed by Novo Nordisk with extensive SAR optimization
  • ≥99% purity confirmed by RP-HPLC and ESI-MS
  • For laboratory research use only

Technical Support

Our team of product experts is available to assist with your research needs.

Contact Support

OEM Services

Need modifications or larger quantities? Request a custom synthesis quote.

Request Custom
Catalog Number IP
Sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Target GHS-R1a (ghrelin receptor)
Molecular Weight ~711.9 Da
Form Lyophilized powder
Purity ≥99% (RP-HPLC)
GH Selectivity No ACTH, cortisol, or prolactin stimulation
Storage -20°C, desiccated
Reconstitution Bacteriostatic water
Shelf Life 24 months (unopened, proper storage)

Need OEM or a Custom Configuration?

We support practical, production-ready customization for peptides, sequences, and modifications. Share your synthesizer type, dimensions, modifications preference, and packaging needs—our team will confirm feasibility and lead time.